Bioinformatics Market

Date: 2016-05

Bioinformatics is the computer technology application that enables scientists to map the human genome. It involves the integration of computers, software tools and databases to get the information that is stored in certain types of biological data.

Based on the type of products, bioinformatics market is segregated into Bioinformatics Platforms, Knowledge Management Tools, and Services. In terms of applications, bioinformatics market is classified into Genomics, Proteomics, Transcriptomics, Metabolomics, Molecular Phylogenetics, Chemoinformatics & Drug Design and others. Bioinformatics market is classified into Medical bioinformatics, Drug Development, Clinical Diagnostics, Molecular Medicine, Gene Therapy, Reproductive Biotechnology, Animal Bioinformatics, Agricultural Bioinformatics, Environmental Bioinformatics, Forensic Bioinformatics, Academics and others based on sector where this technology can be applied.

On the basis of geography bioinformatics market is segmented into North-America, Asia-Pacific, Europe, Latin-America and MEA. North America accounts for the largest market share for bioinformatics owing to the higher adoption rate among region. Asia-Pacific is estimated to witness strong growth due to rise in Contract Research Organizations (CROs) and increased research outsourcing.

The major players in the bioinformatics market including other key players are:
Accelrys, Inc.
Affymetrix, Inc.
Agilent Technologies, Inc.
Geneva bioinformatics
Non linear dynamics
Quest Diagnostics, Inc.
Life Technologies corp.,.

The report also contains detailed and in-depth analysis of the segmentation of the bioinformatics market with respect to geographic regions The regions contained in the report have been segmented into North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW). These regions are further categorized into eminent countries from the perspective of bioinformatics market.


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample